ArticleOncology letters2018

Toll-like receptor agonist rMBP-NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer.

Cong Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.